Closed |
S0526 |
Phase II Trial of Pemetrexed in Stage IIIB and IV BAC |
7/1/2006 |
10/1/2008 |
25% |
|
Published
|
Closed |
S0421 |
Advanced Prostate |
8/21/2006 |
5/1/2010 |
99% |
|
Published
|
Closed |
S0601 |
NON-HODGKINS: R-CHOP-V followed by VM maintenance therapy for MCL |
8/15/2006 |
6/1/2008 |
100% |
|
Published
|
Closed |
S0536 |
Phase II Carboplatin, Paclitaxel, Cetuximab and Bevacizumab in Adv. NSCLC |
8/15/2006 |
9/15/2007 |
100% |
|
Published
|
Closed |
S0528 |
Phase I Study of Lapatinib and Everolimus in Advanced Solid Tumors |
9/1/2006 |
8/25/2009 |
100% |
|
Published
|
Closed |
S0530 |
Phase II Relapsed or Refractory ALL |
10/1/2006 |
8/1/2008 |
100% |
|
Published
|
Closed |
S0500 |
ADVANCED: Therapeutic Strategy Using the CellSearch Assay for Metastatic Breast Cancer |
10/1/2006 |
3/15/2012 |
100% |
|
Published
|
Closed |
S0353 |
Local Bladder |
11/15/2006 |
10/15/2009 |
100% |
|
Published
|
Closed |
S0622 |
ADVANCED: Phase II Dasatinib Treatment for Bone-Metastasis Predominant MBC |
3/15/2007 |
12/15/2010 |
100% |
|
Published
|
Closed |
S0521 |
Phase III Maint. vs. Obs. for Low and Intermediate Risk APL |
6/1/2007 |
|
19% |
|
Published
|
Closed |
S0600 |
Colorectal Ph III irinotecan-based chemo + cetuximab or bevacizumab |
6/15/2007 |
11/10/2010 |
11% |
|
Published
|
Closed |
S0518 |
CARCINOID Ph III depot octreotide + either interferon alpha or bevacizumab |
12/1/2007 |
9/1/2012 |
100% |
|
Published
|
Closed |
S0727 |
Pancreas Ph I/II gemcitabine, erlotinib, IMC-A12 |
3/1/2008 |
9/1/2010 |
100% |
|
Published
|
Closed |
S0777 |
Phase III LD vs. VLD for Induction, followed by Transplant in Multiple Myeloma |
4/1/2008 |
2/1/2012 |
100% |
|
Published
|
Closed |
S0502 |
GIST Ph III imatinib with or without bevacizumab |
4/15/2008 |
10/1/2009 |
2% |
|
Published
|
Closed |
S0000D |
Adenomatous Colorectal Polyps (ACP) |
6/3/2008 |
5/28/2013 |
100% |
|
Published
|
Closed |
S0720 |
Phase II Adjuvant NSCLC |
11/15/2008 |
5/15/2012 |
100% |
|
Published
|
Closed |
S0703 |
Phase II Older Previously Untreated Non-M3 AML |
12/1/2008 |
|
93% |
|
Published
|
Closed |
S0809 |
Cholangiocarcinoma Ph II capecitabine, gemcitabine, RT |
12/1/2008 |
10/1/2012 |
100% |
|
Published
|
Closed |
S0709 |
Phase II Carboplatin/Paclitaxel/Erlotinib vs Erlotinib Alone in Advanced NSCLC |
12/1/2008 |
9/15/2014 |
54% |
|
Published
|